InvestorsObserver
×
News Home

What is the Market's View on Adagio Therapeutics Inc (ADGI) Stock's Price and Volume Trends Thursday?

Thursday, August 18, 2022 03:33 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Adagio Therapeutics Inc (ADGI) Stock's Price and Volume Trends Thursday?

Overall market sentiment has been high on Adagio Therapeutics Inc (ADGI) stock lately. ADGI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Adagio Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ADGI!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ADGI Stock Today?

Adagio Therapeutics Inc (ADGI) stock is trading at $4.42 as of 3:33 PM on Thursday, Aug 18, a gain of $0.40, or 9.99% from the previous closing price of $4.02. The stock has traded between $3.86 and $4.55 so far today. Volume today is above average. So far 1,992,860 shares have traded compared to average volume of 536,561 shares. To screen for more stocks like Adagio Therapeutics Inc click here.

More About Adagio Therapeutics Inc

Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease 2019, or COVID-19, the disease caused by the virus SARS-CoV-2 and its variants. Click Here to get the full Stock Report for Adagio Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App